Filter
17
Filtered Results: 17
Text search:
B.
Durovnia
Featured
Recommendations
3
New Publications
2
Language
Document type
No document type
9
Studies & Reports
3
Manuals
2
Guidelines
2
Training Material
1
Countries / Regions
Russia
2
Ukraine
1
Latin America and the Carribbean
1
Eastern Europe
1
Brazil
1
Authors & Publishers
Publication Years
Category
TB
4
Bacteriology
1
Policies & Guidelines HIV & TB
1
Studies & Reports
1
Toolboxes
Policies & Strategies
4
Prevention & Control
4
Adults
2
General
2
Drug resistant TB
2
Policies and guidelines
2
TB/HIV Global
2
Training
2
TB/HIV Coinfection
2
Epidemiology
2
Childhood TB
1
Vaccines & Immunization
1
Eastern Europe
1
Prophylaxis
1
Vaccination
1
Russia
1
TB/HIV
1
Brazil
1
Detection & Diagnosis
1
Prophylactic Treatment
1
Research & Access
1
Clinical Guidelines
1
AmR (Region of Americas)
1
TB
1
Eastern Europe & Central Asia
1
Moving avidence into action
This document is part of a series of briefs for health program managers interested in implementing evidence-based programs. With a special emphasis on underutilized interventions, they present evidence on programs that work and provide guidance and resources for replicat...
Guidelines for national programmes and other stakeholders
世界卫生组织 结核菌/艾滋病病毒双 重感染防治政策指南
——适用于国家规划 和利益攸关方
Для создания этого отчета MSF исследовала программы и практику лечения лекарственно-чувствительного и лекарственно-устойчивого туберкулеза в восьмистранах с высо...
Цель настоящего документа («Основные положения») заключается в подготовке рекомендаций относительно необходимых на национальном уровне мер по адаптации стратег...
Цель этого документа – повысить уровень осознания актуальности приоритетных направлений научных исследований по проблеме ТБ/ВИЧ (то есть по тем направлениям, кот...
International Journal of Infectious Diseases 32 (2015) 170–178
http://dx.doi.org/10.1016/j.ijid.2014.11.023
1201-9712/ß 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http:...
braz j infect dis. 2014;18(5):491–495
http://dx.doi.org/10.1016/j.bjid.2014.02.004
1413-8670/© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The gu...
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Research Article
Karo et al. BMC Infectious Diseases 2014, 14:148 http://www.biomedcentral.com/1471-2334/14/148
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
The Lancet Global Health January 24, 2022
